Natriuretic Peptide Receptor As A Biomarker For Diagnosis And Prognosis Of Cancer

Abstract

The invention pertains to biomarkers for clinical detection of malignancies, especially for early detection of cancers. More specifically, this invention pertains to the role of Natriuretic Peptide Receptor A (NPRA) in cancer (e.g., tumor) progression. Thus, the invention includes materials and methods for the detection and prognosis of malignancies. The invention also pertains to methods for treating malignancies.


Claims
CPC Classifications
Download PDF
Document Preview
Document History
  • Publication: Jan 22, 2019
  • Application: Mar 16, 2012
    US US 201213422880 A
  • Priority: Mar 16, 2012
    US US 201213422880 A
  • Priority: Mar 17, 2011
    US US 201161453646 P

Download Citation


Sign in to the Lens

Feedback